| Patent Number | Grant Date | Title | Applicant |
|---|---|---|---|
| EP3076983 | Aug 14, 2024 | Ionic Aqueous Compositions | GEROLYMATOS INTERNATIONAL S.A. |
| EP3102208 | Jul 17, 2024 | Crystalline Polymorphs Of The Free Base Of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. |
| EP3578169 | Jun 26, 2024 | Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol | GLAXO GROUP LIMITED |
| EP2104490 | Jun 26, 2024 | Micronised Particles Of Low-Dosage Strength Active Agents For Powder Formulations For Inhalation | CHIESI FARMACEUTICI S.P.A. |
| EP1962797 | May 29, 2024 | Powder Compositions For Inhalation | JAGOTEC AG |
| EP3256569 | Apr 17, 2024 | Alveolar-Like Macrophages And Method Of Generating Same | THE HOSPITAL FOR SICK CHILDREN |
| EP3294770 | Mar 20, 2024 | Therapeutic And Diagnostic Methods For Cancer | F. HOFFMANN-LA ROCHE AG |
| EP3293202 | Feb 7, 2024 | Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses Thereof | CANTARGIA AB |
| EP3209295 | Dec 6, 2023 | Methods Of Treating Ocular Conditions | OYSTER POINT PHARMA, INC. |
| EP2679681 | Nov 15, 2023 | Fc Riib-Specific Fc Antibody | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| Patent Number | Grant Date | Title | Applicant | Facing Oppositions |
|---|---|---|---|---|
| EP2228064 | Dec 11, 2019 | Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist | NOVARTIS PHARMA GMBH | 20 |
| EP2637664 | Mar 29, 2017 | Compositions And Methods Of Treating Pulmonary Hypertension | GILEAD SCIENCES, INC. | 12 |
| EP2400950 | May 22, 2019 | Pharmaceutical Formulations Comprising 4 {(1r) 2 [(6 {2 [(2,6 Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino] 1 Hydroxyethyl} 2 (Hydroxymethyl)Phenol | GLAXO GROUP LIMITED | 8 |
| EP3293202 | Feb 7, 2024 | Anti Human Interleukin 1 Receptor Accessory Protein (Il1rap) Antibodies And Uses Thereof | CANTARGIA AB | 6 |
| EP2506844 | Dec 20, 2017 | Combinations Of A Muscarinic Receptor Antagonist And A Beta 2 Adrenoreceptor Agonist | GLAXO GROUP LIMITED | 6 |
| EP1962797 | May 29, 2024 | Powder Compositions For Inhalation | JAGOTEC AG | 6 |
| EP2506850 | May 13, 2020 | Methods Of Administering Pirfenidone Therapy | INTERMUNE, INC. | 6 |
| EP3107575 | Sep 1, 2021 | Methods For Treating Or Preventing Asthma By Administering An Il 4r Antagonist | REGENERON PHARMACEUTICALS, INC. | 6 |
| EP2447254 | Dec 6, 2017 | Crystals | NIPPON SHINYAKU CO., LTD. | 6 |
| EP3650019 | Oct 11, 2023 | Fluticasone Furoate In The Treatment Of Copd | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED | 6 |
Feel free to send us a message here and we will get back to you